ArticleClinical cancer research : an official journal of the American Association for Cancer Research2023

Preclinical Study of a Biparatopic METxMET Antibody-Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant NSCLC.

Seung Yeon Oh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.